共 158 条
[1]
Lou Y(2018)Improved long-term survival in all Sanz risk patients of newly diagnosed acute promyelocytic leukemia treated with a combination of retinoic acid and arsenic trioxide-based front-line therapy Hematol Oncol 36 584-590
[2]
Lu Y(2019)The factors affecting early death in newly diagnosed APL patients Open Med 14 647-652
[3]
Zhu Z(2020)Real-life outcomes of unselected acute promyelocytic leukemia patients: a single-center 14-year experience Rom J Intern Med 58 138-145
[4]
Ma Y(2020)Early death in acute promyelocytic leukemia: evidence from a rural cancer center Indian J Cancer 57 451-456
[5]
Suo S(2021)Characteristics and predictors of early hospital deaths in newly diagnosed APL: a 13-year population-wide study Blood Adv 5 2829-2838
[6]
Wang Y(2018)The global problem of early deaths in acute promyelocytic leukemia: a strategy to decrease induction mortality in the most curable leukemia Blood Rev 32 89-95
[7]
Ciftciler R(2018)Chinese guidelines for diagnosis and treatment of acute promyelocytic leukemia (2018) Zhonghua Xue Ye Xue Za Zhi 39 179-183
[8]
Haznedaroglu IC(2003)Revised recommendations of the international working Group for Diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia J Clin Oncol 21 4642-4649
[9]
Aksu S(2000)Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups Blood 96 7-783
[10]
Ozcebe O(1992)The ‘retinoic acid syndrome’ in acute Promyelocytic leukemia Ann Intern Med 117 292-e164